GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.11e-05 | 5.92e-01 | 7.656 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 2.39e-04 | 1.00e+00 | 4.549 | 3 | 17 | 168 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.47e-04 | 1.00e+00 | 6.147 | 2 | 5 | 37 |
GO:0005654 | nucleoplasm | 7.42e-04 | 1.00e+00 | 2.599 | 5 | 64 | 1082 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0014889 | muscle atrophy | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0000502 | proteasome complex | 8.54e-04 | 1.00e+00 | 5.499 | 2 | 3 | 58 |
GO:0010467 | gene expression | 1.17e-03 | 1.00e+00 | 2.971 | 4 | 45 | 669 |
GO:0006429 | leucyl-tRNA aminoacylation | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0008193 | tRNA guanylyltransferase activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0004823 | leucine-tRNA ligase activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0051082 | unfolded protein binding | 2.18e-03 | 1.00e+00 | 4.817 | 2 | 7 | 93 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0007023 | post-chaperonin tubulin folding pathway | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0050920 | regulation of chemotaxis | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0044267 | cellular protein metabolic process | 4.78e-03 | 1.00e+00 | 3.053 | 3 | 20 | 474 |
GO:0006457 | protein folding | 5.06e-03 | 1.00e+00 | 4.197 | 2 | 7 | 143 |
GO:0002161 | aminoacyl-tRNA editing activity | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 7 |
GO:0006974 | cellular response to DNA damage stimulus | 5.63e-03 | 1.00e+00 | 4.118 | 2 | 7 | 151 |
GO:0001955 | blood vessel maturation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0016272 | prefoldin complex | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0006450 | regulation of translational fidelity | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 2 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0070628 | proteasome binding | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0003714 | transcription corepressor activity | 7.74e-03 | 1.00e+00 | 3.881 | 2 | 11 | 178 |
GO:0005515 | protein binding | 8.30e-03 | 1.00e+00 | 0.970 | 9 | 198 | 6024 |
GO:0045662 | negative regulation of myoblast differentiation | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0061136 | regulation of proteasomal protein catabolic process | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0005737 | cytoplasm | 9.75e-03 | 1.00e+00 | 1.285 | 7 | 124 | 3767 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 1 | 17 |
GO:0008134 | transcription factor binding | 1.40e-02 | 1.00e+00 | 3.438 | 2 | 18 | 242 |
GO:0032757 | positive regulation of interleukin-8 production | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 20 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 23 |
GO:0048589 | developmental growth | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 26 |
GO:0004866 | endopeptidase inhibitor activity | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 29 |
GO:0042594 | response to starvation | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 2.49e-02 | 1.00e+00 | 5.312 | 1 | 8 | 33 |
GO:0016592 | mediator complex | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 10 | 35 |
GO:0004221 | ubiquitin thiolesterase activity | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 36 |
GO:0043565 | sequence-specific DNA binding | 2.74e-02 | 1.00e+00 | 2.922 | 2 | 11 | 346 |
GO:0005829 | cytosol | 2.85e-02 | 1.00e+00 | 1.393 | 5 | 86 | 2496 |
GO:0005634 | nucleus | 2.89e-02 | 1.00e+00 | 1.010 | 7 | 159 | 4559 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 3 | 42 |
GO:0016579 | protein deubiquitination | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 1 | 42 |
GO:0008344 | adult locomotory behavior | 3.31e-02 | 1.00e+00 | 4.897 | 1 | 2 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 4 | 46 |
GO:0006355 | regulation of transcription, DNA-templated | 3.57e-02 | 1.00e+00 | 1.980 | 3 | 43 | 997 |
GO:0009986 | cell surface | 3.61e-02 | 1.00e+00 | 2.706 | 2 | 9 | 402 |
GO:0004197 | cysteine-type endopeptidase activity | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 1 | 50 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 51 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.89e-02 | 1.00e+00 | 2.646 | 2 | 30 | 419 |
GO:0000226 | microtubule cytoskeleton organization | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 2 | 52 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0044822 | poly(A) RNA binding | 4.14e-02 | 1.00e+00 | 1.897 | 3 | 50 | 1056 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0051087 | chaperone binding | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 3 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 6 | 59 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 2 | 61 |
GO:0004843 | ubiquitin-specific protease activity | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 1 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 2 | 70 |
GO:0006334 | nucleosome assembly | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 3 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 1 | 72 |
GO:0009791 | post-embryonic development | 5.43e-02 | 1.00e+00 | 4.167 | 1 | 3 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0003677 | DNA binding | 5.93e-02 | 1.00e+00 | 1.691 | 3 | 49 | 1218 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 6.37e-02 | 1.00e+00 | 3.930 | 1 | 8 | 86 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 1 | 92 |
GO:0005770 | late endosome | 6.87e-02 | 1.00e+00 | 3.817 | 1 | 2 | 93 |
GO:0010951 | negative regulation of endopeptidase activity | 7.65e-02 | 1.00e+00 | 3.656 | 1 | 6 | 104 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 7.73e-02 | 1.00e+00 | 3.642 | 1 | 8 | 105 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 8.50e-02 | 1.00e+00 | 3.499 | 1 | 3 | 116 |
GO:0007050 | cell cycle arrest | 9.06e-02 | 1.00e+00 | 3.402 | 1 | 5 | 124 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.20e-02 | 1.00e+00 | 3.379 | 1 | 5 | 126 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.66e-02 | 1.00e+00 | 1.908 | 2 | 39 | 699 |
GO:0045202 | synapse | 9.90e-02 | 1.00e+00 | 3.269 | 1 | 5 | 136 |
GO:0016055 | Wnt signaling pathway | 1.00e-01 | 1.00e+00 | 3.248 | 1 | 4 | 138 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 4 | 150 |
GO:0000398 | mRNA splicing, via spliceosome | 1.18e-01 | 1.00e+00 | 2.999 | 1 | 15 | 164 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.19e-01 | 1.00e+00 | 1.733 | 2 | 41 | 789 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 22 | 184 |
GO:0016071 | mRNA metabolic process | 1.58e-01 | 1.00e+00 | 2.556 | 1 | 8 | 223 |
GO:0008380 | RNA splicing | 1.61e-01 | 1.00e+00 | 2.524 | 1 | 22 | 228 |
GO:0003713 | transcription coactivator activity | 1.67e-01 | 1.00e+00 | 2.468 | 1 | 24 | 237 |
GO:0016070 | RNA metabolic process | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 8 | 247 |
GO:0005874 | microtubule | 1.74e-01 | 1.00e+00 | 2.397 | 1 | 7 | 249 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.84e-01 | 1.00e+00 | 2.312 | 1 | 23 | 264 |
GO:0043231 | intracellular membrane-bounded organelle | 2.18e-01 | 1.00e+00 | 2.044 | 1 | 6 | 318 |
GO:0008283 | cell proliferation | 2.24e-01 | 1.00e+00 | 1.999 | 1 | 14 | 328 |
GO:0007268 | synaptic transmission | 2.26e-01 | 1.00e+00 | 1.982 | 1 | 5 | 332 |
GO:0003723 | RNA binding | 2.32e-01 | 1.00e+00 | 1.939 | 1 | 18 | 342 |
GO:0046982 | protein heterodimerization activity | 2.55e-01 | 1.00e+00 | 1.787 | 1 | 8 | 380 |
GO:0005524 | ATP binding | 2.60e-01 | 1.00e+00 | 1.015 | 2 | 31 | 1298 |
GO:0000278 | mitotic cell cycle | 2.61e-01 | 1.00e+00 | 1.746 | 1 | 15 | 391 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.74e-01 | 1.00e+00 | 1.667 | 1 | 24 | 413 |
GO:0043066 | negative regulation of apoptotic process | 2.80e-01 | 1.00e+00 | 1.629 | 1 | 16 | 424 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.10e-01 | 1.00e+00 | 1.456 | 1 | 24 | 478 |
GO:0016032 | viral process | 3.40e-01 | 1.00e+00 | 1.296 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 3.51e-01 | 1.00e+00 | 1.240 | 1 | 12 | 555 |
GO:0016020 | membrane | 3.73e-01 | 1.00e+00 | 0.642 | 2 | 46 | 1681 |
GO:0070062 | extracellular vesicular exosome | 5.68e-01 | 1.00e+00 | 0.128 | 2 | 57 | 2400 |
GO:0044281 | small molecule metabolic process | 6.19e-01 | 1.00e+00 | 0.115 | 1 | 20 | 1211 |
GO:0005886 | plasma membrane | 8.86e-01 | 1.00e+00 | -0.978 | 1 | 49 | 2582 |